Literature DB >> 5158233

Vascular changes in tumours after treatment with ICRF 159.

A W Le Serve, K Hellmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5158233      PMCID： PMC1665898     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  Control of malignant metastases by ICRF l59.

Authors:  K Hellmann; K Burrage
Journal:  Nature       Date:  1969-10-18       Impact factor: 49.962

2.  Drug-induced inhibition of tumour cell dissemination.

Authors:  K Burrage; K Hellmann; A J Salsbury
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

3.  Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Br Med J       Date:  1970-11-07

4.  Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study.

Authors:  G MAJNO; G E PALADE; G I SCHOEFL
Journal:  J Biophys Biochem Cytol       Date:  1961-12
  4 in total
  1 in total

1.  Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine.

Authors:  Maite Verreault; Dita Strutt; Dana Masin; Malathi Anantha; Andrew Yung; Piotr Kozlowski; Dawn Waterhouse; Marcel B Bally; Donald T Yapp
Journal:  BMC Cancer       Date:  2011-04-08       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.